Clotrimazole and Betamethasone Dipropionate NDC 68462-298

NDC codes

FDA NDC Directory

Product NDC (as listed)68462-298Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68462-0298Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68462-298-17	68462029817	15 g in 1 TUBE (68462-298-17)Marketed from Nov 6, 2015
68462-298-55	68462029855	45 g in 1 TUBE (68462-298-55)Marketed from Nov 6, 2015

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Clotrimazole and Betamethasone Dipropionate
Generic name (nonproprietary): clotrimazole and betamethasone dipropionate
Active ingredients: Clotrimazole — 10 mg/gBetamethasone dipropionate — .5 mg/g
Dosage form: Cream
Route: Topical
Labeler: Glenmark Pharmaceuticals Inc. USA
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202894
Marketing start: Nov 6, 2015
Listing expires: Dec 31, 2026
Other FDA classes: Azoles (Chemical structure)Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 68462-298_2fc6dcb9-879f-4d6e-8194-4a30af922986SPL ID 2fc6dcb9-879f-4d6e-8194-4a30af922986SPL set ID 8dcd24cb-e568-428a-88ac-737d115cc54dRxCUI 308714UNII G07GZ97H65, 826Y60901UUPC 0368462298176, 0368462298558
Pharmacologic class: Azole Antifungal; Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468462029817 followed by a unit qualifier and the quantity

Package 68462-0298-17. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 9, 2020.

Indications (excerpt from the label)

Clotrimazole and betamethasone dipropionate cream is a combination of an azole antifungal and corticosteroid and is indicated for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to Epidermophyton floccosum, Trichophyton mentagrophytes, and Trichophyton rubrum in patients 17 years and older. Clotrimazole and betamethasone dipropionate cream contains a combination of clotrimazole, an azole antifungal, and betamethasone dipropionate, a corticosteroid, and is indicated for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to Epidermophyton floccosum, Trichophyton mentagrophytes, and Trichophyton…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 202894

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202894
Product	Strength	Form · route	Labeler	Product NDC
Clotrimazole And Betamethasone Dipropionate	Clotrimazole 10 mg/g; Betamethasone dipropionate .5 mg/g	CreamTopical	Direct Rx	72189-182
Clotrimazole and Betamethasone Dipropionate	Clotrimazole 10 mg/g; Betamethasone dipropionate .5 mg/g	CreamTopical	Proficient Rx LP	71205-524
Clotrimazole and Betamethasone Dipropionate	Clotrimazole 10 mg/g; Betamethasone dipropionate .5 mg/g	CreamTopical	NuCare Pharmaceuticals,Inc.	68071-4134